Tryp Therapeutics 2021 Psychedelic Drug Development Corporate Presentation

Tryp Therapeutics is developing psilocybin-based therapies for chronic pain and other indications as part of the emerging psychedelic drug development field. The presentation outlines the company's research focus, clinical development strategy, and regulatory framework for psychedelic compounds beyond mental health applications.